MX9707735A - NOVEL USE OF (S)-ADENOSYL-L-METHIONINE (SAMe) - Google Patents

NOVEL USE OF (S)-ADENOSYL-L-METHIONINE (SAMe)

Info

Publication number
MX9707735A
MX9707735A MX9707735A MX9707735A MX9707735A MX 9707735 A MX9707735 A MX 9707735A MX 9707735 A MX9707735 A MX 9707735A MX 9707735 A MX9707735 A MX 9707735A MX 9707735 A MX9707735 A MX 9707735A
Authority
MX
Mexico
Prior art keywords
same
adenosyl
methionine
novel use
ischaemia
Prior art date
Application number
MX9707735A
Other languages
Spanish (es)
Inventor
Georg Nemeth
Carlo Di Padova
Laszlo Szabo
Gerhard Gross
Original Assignee
Knoll Ag
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Knoll Ag filed Critical Knoll Ag
Publication of MX9707735A publication Critical patent/MX9707735A/en

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/70—Carbohydrates; Sugars; Derivatives thereof
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/70—Carbohydrates; Sugars; Derivatives thereof
    • A61K31/7042—Compounds having saccharide radicals and heterocyclic rings
    • A61K31/7052—Compounds having saccharide radicals and heterocyclic rings having nitrogen as a ring hetero atom, e.g. nucleosides, nucleotides
    • A61K31/706—Compounds having saccharide radicals and heterocyclic rings having nitrogen as a ring hetero atom, e.g. nucleosides, nucleotides containing six-membered rings with nitrogen as a ring hetero atom
    • A61K31/7064—Compounds having saccharide radicals and heterocyclic rings having nitrogen as a ring hetero atom, e.g. nucleosides, nucleotides containing six-membered rings with nitrogen as a ring hetero atom containing condensed or non-condensed pyrimidines
    • A61K31/7076—Compounds having saccharide radicals and heterocyclic rings having nitrogen as a ring hetero atom, e.g. nucleosides, nucleotides containing six-membered rings with nitrogen as a ring hetero atom containing condensed or non-condensed pyrimidines containing purines, e.g. adenosine, adenylic acid
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Veterinary Medicine (AREA)
  • Chemical & Material Sciences (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Animal Behavior & Ethology (AREA)
  • Molecular Biology (AREA)
  • Epidemiology (AREA)
  • Organic Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Saccharide Compounds (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)

Abstract

The use of SAMe and its physiologically acceptable salts in doses of over 2000 mg per day and patient for the parenteral treatment of conditions triggered by focal permanent ischaemia.
MX9707735A 1995-04-26 1996-04-13 NOVEL USE OF (S)-ADENOSYL-L-METHIONINE (SAMe) MX9707735A (en)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
DE19515275A DE19515275A1 (en) 1995-04-26 1995-04-26 New use of (S) -denosyl-L-methionine (SAMe)
PCT/EP1996/001570 WO1996033727A1 (en) 1995-04-26 1996-04-13 NOVEL USE OF (S)-ADENOSYL-L-METHIONINE (SAMe)

Publications (1)

Publication Number Publication Date
MX9707735A true MX9707735A (en) 1997-12-31

Family

ID=7760373

Family Applications (1)

Application Number Title Priority Date Filing Date
MX9707735A MX9707735A (en) 1995-04-26 1996-04-13 NOVEL USE OF (S)-ADENOSYL-L-METHIONINE (SAMe)

Country Status (15)

Country Link
EP (1) EP0822820A1 (en)
JP (1) JPH11504023A (en)
KR (1) KR19990008061A (en)
CN (1) CN1182367A (en)
AR (1) AR001687A1 (en)
AU (1) AU5646396A (en)
CA (1) CA2216854A1 (en)
CZ (1) CZ330597A3 (en)
DE (1) DE19515275A1 (en)
HR (1) HRP960196A2 (en)
IL (1) IL117844A0 (en)
MX (1) MX9707735A (en)
NO (1) NO974941D0 (en)
WO (1) WO1996033727A1 (en)
ZA (1) ZA963296B (en)

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
IE37913B1 (en) * 1972-08-02 1977-11-09 Bioresearch Sas Salt of s-adenosyl-l-methionine
JPS59139319A (en) * 1983-01-31 1984-08-10 Fuji Kagaku Kogyo Kk Remedy for body dysfunction caused by cerebral disorder
JPH02290896A (en) * 1989-04-28 1990-11-30 Fuji Kagaku Kogyo Kk Novel s-adenosylmethionine derivative
DE4425280C2 (en) * 1994-07-16 1997-05-07 Knoll Ag Use of (S) -denosyl-L-methionine and its physiologically tolerable salts for the treatment of reperfusion damage that is triggered after temporary focal ischemia

Also Published As

Publication number Publication date
CN1182367A (en) 1998-05-20
HRP960196A2 (en) 1998-02-28
EP0822820A1 (en) 1998-02-11
CA2216854A1 (en) 1996-10-13
AU5646396A (en) 1996-11-18
KR19990008061A (en) 1999-01-25
ZA963296B (en) 1997-10-27
DE19515275A1 (en) 1996-10-31
JPH11504023A (en) 1999-04-06
IL117844A0 (en) 1996-08-04
WO1996033727A1 (en) 1996-10-31
NO974941L (en) 1997-10-24
AR001687A1 (en) 1997-11-26
NO974941D0 (en) 1997-10-24
CZ330597A3 (en) 1998-02-18

Similar Documents

Publication Publication Date Title
PL325825A1 (en) Microemulsion for use as a carrier for administering active compounds
CA2263561A1 (en) Thienopyrimidines
MX9701342A (en) Cosolvent parenteral formulation of tirilazad.
MY115662A (en) Novel compounds with analgesic effect
ZA944347B (en) The use of cetrorelix and other nona- and decapeptides in the preparation of a medicament for combating aids and for growth stimulation
HK1030885A1 (en) The use of isatin and oxindole derivatives in the preparation of a medicament for use in the treatment of mycobacterial disease
CA2176298A1 (en) A single high dose fluoroquinolone treatment
ZA922297B (en) Crystalline tiababine monohydrate,its preparation and use
DE59204364D1 (en) Dental patient chair.
MY121623A (en) Methods of preventing breast cancer.
GR3015431T3 (en) Use of acetyl L-carnitine in the therapeutic treatment of coma.
LV11728A (en) Pharmaceutical composition
MX9707642A (en) Pharmaceutical agents for the treatment of alzheimer's disease.
NZ294878A (en) Water soluble derivatives of epipodophyllotoxin and medicaments
MXPA02011533A (en) NOVEL FORMULATIONS OF agr; 2, 4 DISULFOPHENYL N TERT BUTYLNITRONE.
IL131478A0 (en) Methods for treatment of scar tissue
TW330933B (en) Furanoeremophilane and eremophilanolide sesquiterpenes for treatment of diabetes
MX9707735A (en) NOVEL USE OF (S)-ADENOSYL-L-METHIONINE (SAMe)
BG106534A (en) Oral solution containing galanthamine and a sweetening agent
HU9500375D0 (en) Use of 4'-iodo-4'-deoxy-doxorubicin for the treatment of amyloidosis
ZA924128B (en) New combination preparations for treatment of Parkinson's disease.
ZA945431B (en) Use of benzydamine in the treatment of pathological conditions caused by TNF
EP0624368A3 (en) Use of a composition for stimulating the synthesis of glutathione in the manufacture of a medicament for the treatment of acquired immune deficiency syndrome.
CA2233677A1 (en) A novel combination of a .beta.-receptor blocker and an opioid
HU913660D0 (en) The use of imidoazepine derivatives for treating of sleep impairments